VKTX
Viking Therapeutics, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -8.3% ·
share flow +21.1% ·
net new positions -9.1%
· formula
Concentrated accumulation: rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 29.61K | $851,871 | n/a | n/a |
| Q2 2026 | 109 | +6 | 57.62M | $2.25B | +10 | −4 |
| Q1 2026 | 106 | -1 | 56.45M | $1.88B | +7 | −8 |
| Q4 2025 | 106 | +1 | 58.95M | $2.07B | +2 | −1 |
| Q3 2025 | 16 | -1 | 41.62M | $1.09B | +2 | −4 |
| Q2 2025 | 15 | 0 | 36.99M | $980.19M | +2 | −2 |
| Q1 2025 | 12 | +3 | 10.64M | $256.98M | +3 | n/a |
| Q4 2024 | 9 | -3 | 10.39M | $418.15M | n/a | −3 |
| Q3 2024 | 11 | -1 | 6.74M | $426.33M | n/a | −1 |
| Q2 2024 | 12 | n/a | 5.57M | $295.04M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 1.86M | +0.2% | $118.02M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 2 | Citadel Advisors ✦ | 1.47M | +215.7% | $93.24M | 0.1% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (passive) | 1.27M | +596.6% | $80.43M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Viking Global Investors ✦ | 721.93K | -46.7% | $45.71M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 463.53K | +581.0% | $29.12M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 6 | D. E. Shaw & Co. ✦ | 456.46K | -13.1% | $28.90M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 7 | Renaissance Technologies ✦ | 184.10K | +15.5% | $11.66M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Millennium Management ✦ | 172.32K | -76.2% | $10.91M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 62.67K | +5.0% | $3.97M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 51.55K | -4.0% | $3.26M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Marshall Wace ✦ | 17.86K | -75.8% | $1.13M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Wellington Management | $2.11M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 9.80K shares, $318 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.